Search
Descriptor English: Remoxipride
Descriptor Spanish: Remoxiprida
Descriptor remoxiprida
Scope note: Agente antipsicótico específico de los receptores D2 de la dopamina. Se ha demostrado su efectividad en el tratamiento de la esquizofrenia.
Descriptor Portuguese: Remoxiprida
Descriptor French: Rémoxipride
Entry term(s): (S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide
Anhydrous, Remoxipride Hydrochloride
FLA-731
FLA731
Hydrochloride Anhydrous, Remoxipride
Hydrochloride, Remoxipride
Monohydrochloride Monohydrate, Remoxipride
Monohydrochloride, Remoxipride
Remoxipride Hydrochloride
Remoxipride Hydrochloride Anhydrous
Remoxipride Monohydrochloride
Remoxipride Monohydrochloride Monohydrate
Remoxipride Monohydrochloride, (R)-Isomer
Remoxipride, (R)-Isomer
Tree number(s): D02.065.277.796
D02.241.223.100.100.796
D02.241.223.100.150.500
D02.455.426.559.389.127.085.796
D02.455.426.559.389.127.150.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D017330
Scope note: An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antipsychotic Agents
Dopamine Antagonists
Registry Number: 0223RD59PE
CAS Type 1 Name: Benzamide, 3-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxy-, (S)-
Previous Indexing: Benzamides (1984-1992)
Public MeSH Note: 93; REMOXIPRIDE was indexed under BENZAMIDES 1984-92
Online Note: use REMOXIPRIDE (NM) to search REMOXIPRIDE 1984-92
History Note: 93; was REMOXIPRIDE (NM) 1984-92
DeCS ID: 30541
Unique ID: D017330
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1993/01/01
Date of Entry: 1992/05/20
Revision Date: 2013/07/08
Remoxipride - Preferred
Concept UI M0026320
Scope note An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.
Preferred term Remoxipride
Entry term(s) (S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide
Remoxipride Hydrochloride - Narrower
Concept UI M0329310
Preferred term Remoxipride Hydrochloride
Entry term(s) Hydrochloride, Remoxipride
Remoxipride Monohydrochloride - Narrower
Concept UI M0329312
Preferred term Remoxipride Monohydrochloride
Entry term(s) Monohydrochloride, Remoxipride
Remoxipride Monohydrochloride, (R)-Isomer - Narrower
Concept UI M0329313
Preferred term Remoxipride Monohydrochloride, (R)-Isomer
Remoxipride, (R)-Isomer - Related but not broader or narrower
Concept UI M0329316
Preferred term Remoxipride, (R)-Isomer
Remoxipride Hydrochloride Anhydrous - Narrower
Concept UI M0582521
Preferred term Remoxipride Hydrochloride Anhydrous
Entry term(s) Anhydrous, Remoxipride Hydrochloride
Hydrochloride Anhydrous, Remoxipride
FLA-731 - Narrower
Concept UI M0350884
Preferred term FLA-731
Entry term(s) FLA731
Remoxipride Monohydrochloride Monohydrate - Narrower
Concept UI M0329311
Preferred term Remoxipride Monohydrochloride Monohydrate
Entry term(s) Monohydrochloride Monohydrate, Remoxipride



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey